[Acneiform eruption secondary to cetuximab with pseudomalignant histopathological changes].
Vidal-Olmo
I
I
Bassas-Vila
J
J
Herrera-Acosta
E
E
Umbert-Millet
P
P
D017486:Acneiform Eruptions / Q000139:chemically induced* / Q000473:pathology; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068818:Cetuximab; D066246:ErbB Receptors / Q000276:immunology; D006801:Humans; D008297:Male
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D066246:ErbB Receptors; D000068818:Cetuximab